Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
Pawel Muranski(National Heart Lung and Blood Institute), Nicholas P. Restifo(Lyell Immunopharma (United States))
Cited by 348
Related Papers
Identification of essential genes for cancer immunotherapy
|Nature|2017|890
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
|Blood|2008|459
BACH2 regulates CD8+ T cell differentiation by controlling access of AP-1 factors to enhancers
|Nature Immunology|2016|329
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy
|JCI Insight|2017|221
Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation
|Stem Cell Research & Therapy|2020|42